Composition and dosage form for sustained effect of levodopa

Details for Australian Patent Application No. 2004285436 (hide)

International Classifications

Event Publications

11 May 2006 PCT application entered the National Phase

PCT publication WO2005/042101 Priority application(s): WO2005/042101

8 January 2009 Application Accepted

Published as AU-B-2004285436

19 March 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 27 Feb 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2005

16 July 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 27 Feb 2009 2005

16 July 2009 Standard Patent Sealed

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.